Accelerated Aging Effects Observed In Vitro after an Exposure to Gamma-Rays Delivered at Very Low and Continuous Dose-Rate Equivalent to 1-5 Weeks in International Space Station.


Journal

Cells
ISSN: 2073-4409
Titre abrégé: Cells
Pays: Switzerland
ID NLM: 101600052

Informations de publication

Date de publication:
15 Oct 2024
Historique:
received: 26 09 2024
revised: 11 10 2024
accepted: 13 10 2024
medline: 25 10 2024
pubmed: 25 10 2024
entrez: 25 10 2024
Statut: epublish

Résumé

Radiation impacting astronauts in their spacecraft come from a "bath" of high-energy rays (0.1-0.5 mGy per mission day) that reaches deep tissues like the heart and bones and a "stochastic rain" of low-energy particles from the shielding and impacting surface tissues like skin and lenses. However, these two components cannot be reproduced on Earth together. The MarsSimulator facility (Toulouse University, France) emits, thanks to a bag containing thorium salts, a continuous exposure of 120 mSv/y, corresponding to that prevailing in the International Space Station (ISS). By using immunofluorescence, we assessed DNA double-strand breaks (DSB) induced by 1-5 weeks exposure in ISS of human tissues evoked above, identified at risk for space exploration. All the tissues tested elicited DSBs that accumulated proportionally to the dose at a tissue-dependent rate (about 40 DSB/Gy for skin, 3 times more for lens). For the lens, bones, and radiosensitive skin cells tested, perinuclear localization of phosphorylated forms of ataxia telangiectasia mutated protein (pATM) was observed during the 1st to 3rd week of exposure. Since pATM crowns were shown to reflect accelerated aging, these findings suggest that a low dose rate of 120 mSv/y may accelerate the senescence process of the tested tissues. A mathematical model of pATM crown formation and disappearance has been proposed. Further investigations are needed to document these results in order to better evaluate the risks related to space exploration.

Identifiants

pubmed: 39451221
pii: cells13201703
doi: 10.3390/cells13201703
pii:
doi:

Substances chimiques

Ataxia Telangiectasia Mutated Proteins EC 2.7.11.1

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : Haut commissariat à l'Investissement
ID : INDIRA Project
Organisme : Centre National d'Etudes Spatiales
ID : ICARE project

Auteurs

Juliette Restier-Verlet (J)

INSERM U1296 Unit "Radiation: Defense, Health, Environment", 28 Rue Laennec, 69008 Lyon, France.

Mélanie L Ferlazzo (ML)

INSERM U1296 Unit "Radiation: Defense, Health, Environment", 28 Rue Laennec, 69008 Lyon, France.

Adeline Granzotto (A)

INSERM U1296 Unit "Radiation: Defense, Health, Environment", 28 Rue Laennec, 69008 Lyon, France.

Joëlle Al-Choboq (J)

INSERM U1296 Unit "Radiation: Defense, Health, Environment", 28 Rue Laennec, 69008 Lyon, France.

Camélia Bellemou (C)

INSERM U1296 Unit "Radiation: Defense, Health, Environment", 28 Rue Laennec, 69008 Lyon, France.

Maxime Estavoyer (M)

Universite Claude Bernard Lyon 1, CNRS, Ecole Centrale de Lyon, INSA Lyon, Université Jean Monnet, ICJ UMR5208, Inria, 69622 Villeurbanne, France.

Florentin Lecomte (F)

Universite Claude Bernard Lyon 1, CNRS, Ecole Centrale de Lyon, INSA Lyon, Université Jean Monnet, ICJ UMR5208, Inria, 69622 Villeurbanne, France.

Michel Bourguignon (M)

INSERM U1296 Unit "Radiation: Defense, Health, Environment", 28 Rue Laennec, 69008 Lyon, France.
Département de Biophysique et Médecine Nucléaire, Université Paris Saclay, Versailles St. Quentin-en-Yvelines, 78035 Versailles, France.

Laurent Pujo-Menjouet (L)

Universite Claude Bernard Lyon 1, CNRS, Ecole Centrale de Lyon, INSA Lyon, Université Jean Monnet, ICJ UMR5208, Inria, 69622 Villeurbanne, France.

Nicolas Foray (N)

INSERM U1296 Unit "Radiation: Defense, Health, Environment", 28 Rue Laennec, 69008 Lyon, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH